LYOPHILIZED INJECTABLE FOR POINT-OF-CARE THERAPEUTIC FOR POST-TRAUMATIC OSTEOARTHRITIS

$5,669,320FY2017Defense Health AgencyDOD

The General Hospital Corporation

Investigators